Atea Pharmaceuticals, Inc. (AVIR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 263.2M | 310.99M | 336.14M | 385.6M | 433.71M | 462.36M | 486.91M | 506.37M | 548.76M | 590.46M | 603.32M | 620.83M |
| Cash & Short-Term Investments | 256.01M | 301.83M | 329.31M | 379.71M | 425.44M | 454.72M | 482.81M | 502.21M | 541.49M | 578.11M | 595.13M | 608.06M |
| Cash Only | 79.32M | 95.71M | 77.34M | 87.72M | 119.39M | 64.7M | 98.46M | 243.39M | 160.91M | 143.82M | 137.89M | 213.7M |
| Short-Term Investments | 176.69M | 206.12M | 251.97M | 291.99M | 306.04M | 390.02M | 384.35M | 258.82M | 380.58M | 434.28M | 457.24M | 394.36M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 7.19M | 9.16M | 6.83M | 0 | 8.27M | 7.63M | 4.09M | 4.16M | 1.29M | 12.35M | 3.75M | 12.76M |
| Total Non-Current Assets | 3.88M | 4.23M | 6.83M | 6M | 6.26M | 2.31M | 4.05M | 4.01M | 4.26M | 4.51M | 4.76M | 5.2M |
| Property, Plant & Equipment | 831K | 1.09M | 1.35M | 1.61M | 1.86M | 2.12M | 2.37M | 2.62M | 2.87M | 3.12M | 3.36M | 3.61M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.05M | 3.14M | 5.47M | 4.39M | 4.39M | 197K | 1.68M | 1.4M | 1.4M | 1.4M | 1.4M | 1.59M |
| Total Assets | 267.08M | 315.22M | 342.96M | 391.61M | 439.96M | 464.67M | 490.96M | 510.38M | 553.03M | 594.97M | 608.08M | 626.03M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -39.3% | -32.16% | -30.14% | -23.27% | -20.44% | -21.9% | -19.26% | -18.47% | -13.34% | -10.76% | -11.43% | -9.84% |
| Total Current Liabilities | 33.37M | 39.78M | 20.18M | 20.12M | 21.75M | 18.6M | 25.19M | 26.62M | 41.31M | 32.38M | 18.89M | 16.16M |
| Accounts Payable | 9.45M | 12.95M | 3.52M | 8.84M | 7.39M | 4.46M | 5.79M | 5.47M | 21.14M | 4.25M | 395K | 3.96M |
| Days Payables Outstanding | 9.69K | - | - | 305.3 | 154.95 | 4.53K | 25.99 | 11.64K | 11.11K | 2.06K | 11.1 | 13.15 |
| Short-Term Debt | 634K | 843K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 23.29M | 26M | 0 | 0 | 0 | 7.44M | 0 | 16.18M | 0 | 0 | 0 | 0 |
| Current Ratio | 7.89x | 7.82x | 16.66x | 19.17x | 19.94x | 24.85x | 19.33x | 19.02x | 13.28x | 18.24x | 31.93x | 38.42x |
| Quick Ratio | 7.89x | 7.82x | 16.66x | 19.17x | 19.94x | 24.85x | 19.33x | 19.02x | 13.28x | 18.24x | 31.93x | 38.42x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 7.01M | 7.07M | 7.13M | 7.2M | 7.25M | 7.29M | 7.35M | 7.4M | 7.45M | 7.52M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 213K | 425K | 634K | 842K | 1.04M | 1.25M | 1.45M | 1.64M | 1.83M | 2.03M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 6.79M | 6.64M | 6.5M | 6.36M | 6.2M | 6.05M | 5.9M | 5.76M | 5.62M | 5.49M |
| Total Liabilities | 33.37M | 39.78M | 27.18M | 27.19M | 28.88M | 25.8M | 32.44M | 33.91M | 48.66M | 39.78M | 26.34M | 23.68M |
| Total Debt | 634K | 843K | 1.04M | 1.25M | 1.45M | 1.64M | 1.83M | 2.02M | 2.21M | 2.4M | 2.58M | 2.77M |
| Net Debt | -78.68M | -94.87M | -76.3M | -86.47M | -117.95M | -63.05M | -96.63M | -241.37M | -158.7M | -141.42M | -135.3M | -210.93M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 233.71M | 275.43M | 315.78M | 364.42M | 411.08M | 438.87M | 458.52M | 476.47M | 504.37M | 555.19M | 581.73M | 602.35M |
| Equity Growth % | -43.15% | -37.24% | -31.13% | -23.52% | -18.5% | -20.95% | -21.18% | -20.9% | -18.41% | -13.33% | -12.28% | -8.8% |
| Book Value per Share | 2.95 | 3.53 | 3.99 | 4.35 | 4.83 | 5.20 | 5.43 | 5.66 | 6.01 | 6.65 | 6.98 | 7.22 |
| Total Shareholders' Equity | 233.71M | 275.43M | 315.78M | 364.42M | 411.08M | 438.87M | 458.52M | 476.47M | 504.37M | 555.19M | 581.73M | 602.35M |
| Common Stock | 80K | 78K | 78K | 81K | 85K | 84K | 84K | 84K | 84K | 83K | 83K | 83K |
| Retained Earnings | -568.01M | -522.57M | -477.7M | -435.65M | -398.49M | -364.22M | -330.68M | -299.53M | -259M | -195.84M | -156.67M | -123.53M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -97K | 174K | 238K | 37K | 118K | 233K | 641K | -280K | -181K | 207K | -262K | -310K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |